New licensing Guidelines issued by the National Institutes of Health at the end of the Biden Administration could harm American biotech innovation and boost China.

Researchers have used artificial intelligence to identify 25 new protein compounds that can kill bacteria and fungi, ...

In November, virologist Beata Halassy announced to the world that she had cured her own breast cancer using a treatment ...

Today, we have a look at the White House's reported plans to make major cuts across federal health agencies. Also, Eli Lilly is expanding the ...

Good news for the sector came January 23 when global pharmaceutical giant AstraZeneca plc announced an eye-popping $820 ...

Alumis Inc. will merge with a Southern California drug developer in a deal that extends the combined companies' cash into ...

According to the CBI, verification of a complaint received by them revealed that of N.N Sabbani working as Computor at Office ...

In a mid-stage study, the candidate itolizumab achieved 23.3% clinical remission rate at 12 weeks, numerically better than ...

The US Food and Drug Administration (FDA) has issued several warning letters to pharmaceutical manufacturers in India and ...

It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their US ...

Japan’s Mitsubishi Chemical Group has resolved, at a meeting of the board of directors held today, to transfer its consolidated subsidiary, Mitsubishi Tanabe Pharma (MTPC), which engages in the ...

IIT Madras launches cancer genome database to transform cancer research in India, aiming to identify biomarkers and ...